Pharmacogenetic Interactions of Rifapentine plus Isoniazid with Efavirenz or Nevirapine

OBJECTIVE: The effect of rifapentine plus isoniazid on efavirenz pharmacokinetics was characterized in AIDS Clinical Trials Group protocol A5279 (NCT01404312). The present analyses characterize pharmacogenetic interactions between these drugs, and with nevirapine. METHODS: A subset of HIV-positive i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacogenet Genomics
Asıl Yazarlar: Haas, David W., Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Mwelase, Noluthando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Baker, Paxton, Fletcher, Courtney V.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655626/
https://ncbi.nlm.nih.gov/pubmed/32815870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000417
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller